ビタミンD検査市場- 世界の産業規模、シェア、動向、機会、予測、製品別、適応症別、エンドユーザー別、地域別、競合別、2020-2030年

ビタミンD検査の世界市場規模は2024年に10億1,000万米ドル、2030年には16億5,000万米ドルに達すると予測、CAGRは8.48%。

世界のビタミンD検査市場は、ビタミンD欠乏症に対する意識の高まり、診断技術の進歩、予防ヘルスケア重視の高まりに後押しされ、一貫した成長を遂げています。ヘルスケアプロバイダー、政府機関、消費者が、全身の健康や疾病予防におけるビタミンDの重要な役割を認識するにつれ、市場は拡大を続けています。

検査不足率の上昇、検査法における最先端の技術革新、積極的なヘルスケアへの取り組み、医療費の増加などを背景に、この業界は持続的な開発が見込まれています。診断ソリューションへのアクセシビリティが向上するにつれて、市場は継続的な成長と技術的進化を遂げ、世界の健康管理における役割が強化されると予想されます。

主な市場促進要因

ビタミンD欠乏症の有病率の上昇

主な市場課題

高い検査費用と限られたアクセス性

主要市場動向

予防ヘルスケアへの注目の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 ビタミンD検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（25-ヒドロキシビタミンDテスト、1,25-ジヒドロキシビタミンDテスト）
  • 適応症別（骨粗鬆症、くる病、甲状腺疾患、ビタミンD欠乏症、その他）
  • エンドユーザー別（病院、診断研究所、在宅ケア、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のビタミンD検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のビタミンD検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のビタミンD検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のビタミンD検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのビタミンD検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のビタミンD検査市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• bioMerieux
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Vitamin D Testing market was valued at USD 1.01 Billion in 2024 and is expected to reach USD 1.65 Billion by 2030 with a CAGR of 8.48%. The Global Vitamin D Testing market is experiencing consistent growth, fueled by heightened awareness of vitamin D deficiency, advancements in diagnostic technologies, and the increasing emphasis on preventive healthcare. As healthcare providers, government agencies, and consumers acknowledge the essential role of vitamin D in overall well-being and disease prevention, the market continues to expand.

The industry is positioned for sustained development, driven by rising deficiency rates, cutting-edge innovations in testing methods, proactive healthcare initiatives, and growing healthcare expenditures. As accessibility to diagnostic solutions improves, the market is expected to experience continuous growth and technological evolution, reinforcing its role in global health management.

Key Market Drivers

Rising Prevalence of Vitamin D Deficiency

The increasing prevalence of vitamin D deficiency has become a major global health concern, significantly driving the demand for vitamin D testing solutions. Vitamin D deficiency is a widespread global health issue, with research indicating high prevalence rates across multiple regions. In India, studies estimate that 50% to 99% of the population may be affected. As awareness grows regarding the critical role of vitamin D in maintaining overall health, healthcare providers, governments, and diagnostic companies are focusing on early detection and intervention, fueling market expansion. Vitamin D deficiency is widespread, affecting populations across various age groups and geographic regions. Epidemiological studies indicate that vitamin D deficiency is highly prevalent among children, with reported rates ranging from 50% to 94%. This widespread deficiency is primarily attributed to insufficient sunlight exposure, inadequate dietary intake, and cultural practices that limit access to vitamin D-rich foods or outdoor activities. Aging populations, as older adults experience reduced vitamin D synthesis in the skin. Medical conditions such as obesity, kidney disease, and malabsorption disorders, which impair vitamin D metabolism.

Governments and healthcare organizations worldwide are implementing public health campaigns to educate individuals about the risks associated with vitamin D deficiency. These initiatives emphasize routine screening, particularly for high-risk groups, including Elderly individuals, who are more susceptible to osteoporosis and fractures. Pregnant women, as vitamin D is essential for fetal development. Patients with chronic illnesses, such as cardiovascular diseases and autoimmune disorders. The integration of vitamin D testing into preventive healthcare programs has led to higher adoption rates, further driving market growth. Scientific research has established a strong correlation between vitamin D deficiency and various chronic conditions, including Osteoporosis & Bone Disorders - Vitamin D is crucial for calcium absorption, and deficiency increases the risk of fractures and bone loss. Studies suggest that low vitamin D levels may contribute to hypertension and heart disease. Deficiency is linked to increased susceptibility to infections and autoimmune disorders. As healthcare providers recognize the importance of vitamin D testing in disease prevention and management, demand for accurate diagnostic solutions continues to rise.

The growing need for efficient and precise vitamin D testing has led to significant advancements in diagnostic technologies. Innovations such as: Chemiluminescence immunoassays (CLIA) for high-sensitivity detection. Liquid chromatography-mass spectrometry (LC-MS) for accurate measurement of vitamin D metabolites. Home-based test kits, enabling individuals to monitor their vitamin D levels conveniently. These advancements have enhanced accessibility, making vitamin D testing more cost-effective and widely available, further accelerating market growth.

Key Market Challenges

High Cost of Testing & Limited Accessibility

Expensive diagnostic procedures remain a significant barrier, particularly in developing regions where healthcare infrastructure is less advanced. Many vitamin D tests, especially 25-hydroxy vitamin D assays, require specialized equipment and trained professionals, increasing operational costs for laboratories and healthcare providers.

The lack of reimbursement policies for routine vitamin D testing in certain countries discourages patients from undergoing regular screenings, limiting market penetration. In rural and underserved areas, access to advanced diagnostic facilities is restricted, preventing widespread adoption of vitamin D testing.

Key Market Trends

Increasing Focus on Preventive Healthcare

The global healthcare landscape is shifting toward preventive care, with a growing emphasis on early diagnosis and proactive management of health conditions. Vitamin D plays a critical role in maintaining bone health, immune function, and cardiovascular stability, making routine testing an essential part of preventive healthcare strategies. Vitamin D deficiency is associated with an array of chronic conditions, including osteoporosis, cardiovascular diseases, autoimmune disorders, and metabolic syndromes. As awareness of these risks increases, healthcare providers and organizations are advocating for regular vitamin D screening, particularly among high-risk populations such as the elderly, individuals with limited sun exposure, and those with underlying health conditions.

Governments and healthcare institutions are implementing public health initiatives that emphasize early detection and intervention to reduce the burden of vitamin D-related diseases. Routine screening is now being integrated into wellness programs, corporate healthcare offerings, and primary care check-ups. Medical professionals are recommending vitamin D testing for patients experiencing fatigue, joint pain, depression, and muscle weakness, which are often linked to deficiencies. Additionally, the rising consumer-driven approach to health and wellness has fueled demand for personalized nutrition plans, where vitamin D assessment plays a significant role. Many individuals are proactively seeking testing services to optimize their vitamin D intake through supplementation, dietary adjustments, and lifestyle modifications. The expanding availability of direct-to-consumer testing kits allows people to monitor their vitamin D levels conveniently, further reinforcing this trend.

Key Market Players

• Abbott Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• bioMerieux
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc

Report Scope:

In this report, the Global Vitamin D Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin D Testing Market, By Product:

• 25-Hydroxy Vitamin D Test
• 1,25-Dihydroxy Vitamin D Test

Vitamin D Testing Market, By Indication:

• Osteoporosis
• Rickets
• Thyroid Disorders
• Vitamin D Deficiency
• Others

Vitamin D Testing Market, By End User:

• Hospitals
• Diagnostic Laboratories
• Homecare
• Others

Vitamin D Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin D Testing Market.

Available Customizations:

Global Vitamin D Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Vitamin D Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (25-Hydroxy Vitamin D Test, 1,25-Dihydroxy Vitamin D Test)
  • 5.2.2. By Indication (Osteoporosis, Rickets, Thyroid Disorders, Vitamin D Deficiency, Others)
  • 5.2.3. By End User (Hospitals, Diagnostic Laboratories, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Vitamin D Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vitamin D Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Vitamin D Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Vitamin D Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End User

7. Europe Vitamin D Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vitamin D Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Vitamin D Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Vitamin D Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. France Vitamin D Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Vitamin D Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By End User

8. Asia-Pacific Vitamin D Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vitamin D Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Vitamin D Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Vitamin D Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Vitamin D Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Vitamin D Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By End User

9. South America Vitamin D Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vitamin D Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Vitamin D Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Vitamin D Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End User

10. Middle East and Africa Vitamin D Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vitamin D Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Vitamin D Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Vitamin D Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Vitamin D Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Danaher Corporation
• 14.3. F. Hoffmann-La Roche Ltd
• 14.4. Siemens Healthineers AG
• 14.5. Quest Diagnostics Incorporated
• 14.6. bioMerieux
• 14.7. DiaSorin S.p.A.
• 14.8. Thermo Fisher Scientific Inc
• 14.9. Beckman Coulter, Inc.
• 14.10.Tosoh Bioscience, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer